Piper Sandler analyst Yasmeen Rahimi initiated coverage of Avalo Therapeutics (AVTX) with an Overweight rating and $48 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTX: